GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RIME · Mar 31, 2026

Algorhythm Holdings, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-022876General Corporate
Capex intensity50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.58% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

20.42% · CORE · NOT_ENOUGH_HISTORY

Gross margin8thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_margin

-28.21% · CORE · VALID

Operating margin17thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-181.00% · CORE · VALID

SBC intensity100thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

38.46% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History14 statesHistory building
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.32%
Current
0.58%
Delta
0.26%
Growth Increased
Previous
-81.31%
Current
20.42%
Delta
101.73%
Margin Increased
Previous
-29.95%
Current
-28.21%
Delta
1.74%
Profitability Increased
Previous
-181.01%
Current
-181.00%
Delta
0.01%
Sbc Intensity Increased
Previous
9.88%
Current
38.46%
Delta
28.57%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.